(NP (NP (NN Induction)) (PP (IN of) (NP-COOD (NP (JJ monocytic) (NN differentiation)) (CC and) (NP (ADJP (NN NF-kappa) (JJ B-like)) (NNS activities)))) (PP (IN by) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (CD 1) (NN infection)) (PP (IN of) (NP (JJ myelomonoblastic) (NNS cells))))) (. .))
(S (NP-SBJ-25 (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN infection))) (PP (IN on) (NP-COOD (NP (JJ cellular) (NN differentiation)) (CC and) (NP (NN NF-kappa) (NN B) (NN DNA) (NN binding) (NN activity))))) (VP (VBP have) (VP (VBN been) (VP (VBN investigated) (NP (-NONE- *-25)) (PP (IN in) (NP (NP (DT a) (JJ new) (NN model)) (PP (IN of) (NP (JJ myeloid) (NN differentiation)))))))) (. .))
(S (NP-SBJ (NN PLB-985) (NNS cells)) (VP (VBP represent) (NP (NP (DT a) (JJ bipotential) (JJ myelomonoblastic) (NN cell) (NN population)) (ADJP (JJ capable) (PP (IN of) (NP (NP (ADJP-COOD (CC either) (ADJP (JJ granulocytic)) (CC or) (ADJP (JJ monocytic))) (NN differentiation)) (PP-TMP (IN after) (NP (NP (NN induction)) (PP (IN with) (NP (JJ appropriate) (NNS inducers)))))))))) (. .))
(S (PP (IN By) (NN virtue) (IN of) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN CD4))) (PP (IN on) (NP (DT the) (NN cell) (NN surface))))) (, ,) (NP-SBJ-26 (NN PLB-985) (NNS cells)) (VP (VBD were) (ADVP (RB chronically)) (VP (VBN infected) (NP (-NONE- *-26)) (PP (IN with) (NP (NN HIV-1) (NN strain) (NN IIIB))))) (. .))
(S (NP-SBJ (NN PLB-IIIB) (NNS cells)) (ADVP (RB clearly)) (VP (VBD possessed) (NP (NP (DT a) (ADJP (RBR more) (JJ monocytic)) (NN phenotype)) (PP (IN than) (NP (DT the) (JJ parental) (NNS myeloblasts)))) (, ,) (SBAR (IN as) (S (NP-SBJ-27 (-NONE- *)) (VP (VBN determined) (NP (-NONE- *-27)) (PP (IN by) (NP-LGS-COOD (NP (JJ differential) (NN staining)) (, ,) (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (DT the) (JJ myeloid-specific) (NN surface) (NNS markers)))) (, ,) (CC and) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NN c-fms) (NN proto-oncogene)))))))))) (. .))
(S (NP-SBJ (NN NF-kappa) (NN B) (NN binding) (NN activity)) (VP (VBD was) (ADJP-PRD (JJ inducible)) (PP (IN by) (NP-COOD (NP (NN tumor) (NN necrosis) (NN factor)) (CC and) (NP (NN phorbol) (NN myristate) (NN acetate)))) (PP (IN in) (NP (NN PLB-985)))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NN PLB-IIIB) (NNS cells))) (, ,) (NP-SBJ-28 (NP (JJ constitutive) (NN expression)) (PP (IN of) (NP (DT a) (JJ novel) (NN NF-kappa) (NN B) (NN complex)))) (VP (VBD was) (VP (VBN detected) (NP-29 (-NONE- *-28)) (, ,) (S (NP-SBJ-30 (-NONE- *-29)) (VP (VBN composed) (NP (-NONE- *-30)) (PP (IN of) (NP (NP (NNS proteins)) (VP (VBG ranging) (PP (IN between) (NP (QP (CD 70) (CC and) (CD 110)) (NN kD)))))))))) (. .))
(S (NP-SBJ (DT These) (NNS proteins)) (VP (VBD interacted) (PP (RB specifically) (IN with) (NP (NP (DT the) (JJ symmetric) (NN NF-kappa) (NN B) (NN site)) (PP (IN from) (NP (DT the) (NP (NP (NN interferon) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN IFN-beta)) (-RRB- -RRB-))) (NN promoter)))))) (. .))
(S (NP-SBJ-31 (NP (NNS Mutations)) (VP (VBG affecting) (NP (NP (DT the) (JJ 5') (JJ guanine) (NNS residues)) (PP (IN of) (NP (DT the) (NN kappa) (NN B) (NN site)))))) (VP (VBD were) (ADJP-PRD (JJ unable) (S (NP-SBJ (-NONE- *-31)) (VP (TO to) (VP (VB compete) (PP (IN for) (NP (DT these) (ADJP (NN NF-kappa) (JJ B-related)) (NNS proteins)))))))) (. .))
(S (NP-SBJ-32 (NP (NN Inducibility)) (PP (IN of) (NP (JJ endogenous) (NP-COOD (NP (NN IFN-beta)) (CC and) (NP (NN IFN-alpha))) (NN RNA)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN increased) (NP (-NONE- *-32)) (PP (IN in) (NP (NN PLB-IIIB) (NNS cells))))) (. .))
(S (NP-SBJ (DT These) (NNS studies)) (VP (VBP indicate) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (NP (NN HIV-1) (NN infection)) (PP (IN of) (NP (JJ myelomonoblastic) (NNS cells)))) (VP (MD may) (VP (VB select) (PP (IN for) (NP (DT a) (ADJP (RBR more) (JJ mature)) (JJ monocytic) (NN phenotype))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (JJ unique) (NN subunit) (NNS associations)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN DNA) (NN binding) (NNS proteins)))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (JJ differential) (ADJP (NN NF-kappa) (JJ B-mediated)) (NN gene) (NN expression))))))))) (. .))
